中性粒细胞靶向脂质纳米颗粒递送PD-L1 siRNA有效改善脓毒症
脓毒症影响全球超过4800万人,中性粒细胞表面程序性死亡配体1(PD-L1)参与脓毒症炎症器官功能障碍和免疫麻痹,但体内特异性靶向中性粒细胞PD-L1的策略匮乏。作者开发了两种通过中性粒细胞特异性抗体和多肽递送PD-L1 siRNA的中性粒细胞靶向脂质纳米颗粒,并进行体内外实验检测其进入中性粒细胞。采用小鼠盲肠结扎穿孔模型检测中性粒细胞迁移、中性粒细胞胞外诱捕网水平和器官损伤。结果显示,靶向中性粒细胞的PD-L1 siRNA负载脂质纳米颗粒抑制炎症、减少中性粒细胞胞外诱捕网释放、抑制T淋巴细胞凋亡,有助于维持脓毒症期间免疫和炎症反应稳态,并可能减轻盲肠结扎穿孔导致的多器官损伤和致死性。
要点
- 中性粒细胞表面PD-L1参与脓毒症炎症器官功能障碍和免疫麻痹,但体内特异性靶向中性粒细胞PD-L1的策略匮乏。
- 作者开发两种中性粒细胞靶向脂质纳米颗粒,分别通过中性粒细胞特异性抗体和多肽递送PD-L1 siRNA。
- 在小鼠盲肠结扎穿孔模型中,PD-L1 siRNA负载脂质纳米颗粒抑制炎症、减少中性粒细胞胞外诱捕网释放、抑制T淋巴细胞凋亡。
- 该策略有助于维持脓毒症期间免疫和炎症反应稳态,并可能减轻盲肠结扎穿孔导致的多器官损伤和致死性。
- 作者认为该中性粒细胞靶向药物递送策略是脓毒症治疗的新颖、安全且有效的方法。
适用人群与场景
- 脓毒症小鼠盲肠结扎穿孔模型
研究设计与关键结果
- 研究类型:基础研究(脂质纳米颗粒递送系统开发与小鼠体内外实验)。
- 干预:两种中性粒细胞靶向脂质纳米颗粒,分别通过中性粒细胞特异性抗体和多肽递送PD-L1 siRNA。
- 模型:小鼠盲肠结扎穿孔模型,检测中性粒细胞迁移、中性粒细胞胞外诱捕网水平和器官损伤。
- 结果:PD-L1 siRNA负载脂质纳米颗粒抑制炎症、减少中性粒细胞胞外诱捕网释放、抑制T淋巴细胞凋亡。
- 结果:该策略有助于维持脓毒症期间免疫和炎症反应稳态,并可能减轻盲肠结扎穿孔导致的多器官损伤和致死性。
证据类型、等级与局限
- 证据类型:基础研究(脂质纳米颗粒递送系统开发与小鼠体内外实验)。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为该中性粒细胞靶向药物递送策略是脓毒症治疗的新颖、安全且有效的方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Sepsis, a complex and life-threatening disease, poses a significant global burden affecting over 48 million individuals. Recently, it has been reported that programmed death-ligand 1 (PD-L1) expressed on neutrophils is involved in both inflammatory organ dysfunction and immunoparalysis in sepsis. However, there is a dearth of strategies to specifically target PD-L1 in neutrophils in vivo . Methods: We successfully developed two lipid nanoparticles (LNPs) specifically targeting neutrophils by delivering PD-L1 siRNA via neutrophil-specific antibodies and polypeptides. In vivo and in vitro experiments were performed to detect lipid nanoparticles into neutrophils. A mouse cecal ligation and puncture model was used to detect neutrophil migration, neutrophil extracellular traps level, and organ damage. Result: The PD-L1 siRNA-loaded LNPs that target neutrophils suppressed inflammation, reduced the release of neutrophil extracellular traps, and inhibited T-lymphocyte apoptosis. This approach could help maintain homeostasis of both the immune and inflammatory responses during sepsis. Furthermore, the PD-L1 siRNA-loaded LNPs targeting neutrophils have the potential to ameliorate the multiorgan damage and lethality resulting from cecal ligation and puncture. Conclusions: Taken together, our data identify a previously unknown drug delivery strategy targeting neutrophils, which represents a novel, safe, and effective approach to sepsis therapy.
参考来源
- Zhu CL, Wang Y, Ren SC, et al. THE DELIVERY OF PD-L1 SIRNA BY NEUTROPHIL-TARGETED LIPID NANOPARTICLES EFFECTIVELY AMELIORATES SEPSIS. Shock. 2024. PMID: 39158541. doi:10.1097/SHK.0000000000002450
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。